Should Drug Manufacturers - Specialty & Generic Stock Cardiol Therapeutics Inc (CRDL) Be in Your Portfolio Tuesday?

The 74 rating InvestorsObserver gives to Cardiol Therapeutics Inc (CRDL) stock puts it near the top of the Drug Manufacturers - Specialty & Generic industry. In addition to scoring higher than 97 percent of stocks in the Drug Manufacturers - Specialty & Generic industry, CRDL’s 74 overall rating means the stock scores better than 74 percent of all stocks.

CRDL has an Overall Score of 74. Find out what this means to you and get the rest of the rankings on CRDL!

See Full CRDL Report

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 74 means the stock is more attractive than 74 percent of stocks. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Cardiol Therapeutics Inc Stock Today?

Cardiol Therapeutics Inc (CRDL) stock is trading at $0.78 as of 12:36 PM on Tuesday, Oct 24, a gain of $0.11, or 15.66% from the previous closing price of $0.67. The stock has traded between $0.70 and $0.79 so far today. Volume today is high. So far 523,379 shares have traded compared to average volume of 323,228 shares. Click Here to get the full Stock Report for Cardiol Therapeutics Inc stock.